Home NDC 68788-8307 AMOXICILLIN AND CLAVULANATE POTASSIUM
Product NDC 68788-8307
11-digit product format 687888307
Labeler code 68788
Product ID 68788-8307_23c2896b-d08f-4948-ac77-e15df706eeac
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name amoxicillin and clavulanate potassium
Dosage form TABLET, COATED
Route ORAL
Labeler Preferred Pharmaceuticals Inc.
Application NDA050720
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2022-12-20
Substance AMOXICILLIN; CLAVULANATE POTASSIUM
Active strength 875; 125 mg/1; mg/1
Pharmacologic classes Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050720-001 AUGMENTIN '875' AMOXICILLIN; CLAVULANATE POTASSIUM 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N050720-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base AMOXICILLIN AND CLAVULANATE POTASSIUM
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMOXICILLIN 875 mg/1 CLAVULANATE POTASSIUM 125 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 804826J2HU Internal UNII lookup Q42OMW3AT8 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 562508 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68788-8307-2 AMOXICILLIN AND CLAVULANATE POTASSIUM 20 in 1 BOTTLE TABLET, COATED 20 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68788-8307 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, COATED [PREFERRED PHARMACEUTICALS INC.] 3 Current NDC, Legacy NDC, 1 package rows 20250205_1b8a6312-ae47-45fb-ba5e-eedbc176afa0.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68788-8307-2 68788830702 20 TABLET, COATED in 1 BOTTLE (68788-8307-2) 2022-12-20 0000-00-00 No No Current